Entity
  • SynHelix (now Quantoom Biosciences, a Univercells Company)

    Created in 2019
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    654 6,849
  • Activities

  • Technologies

  • Entity types

  • Location

    4 Rue Pierre Fontaine, 91000 Évry-Courcouronnes, France

    Évry-Courcouronnes

    France

  • Employees

    Scale: 11-50, 51-200

    Estimated: 123

  • SIREN

    848917373
  • Engaged corporates

    2
    2 1
  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Large-scale DNA synthesis technology that harnesses natural enzymes.

    Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.

    Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology

  • Original language

    Large-scale DNA synthesis technology that harnesses natural enzymes.

    Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.

  • Quantoom Biosciences mRNA production reinvented

    We are a team of scientists, engineers & clinicians committed to solving some of the biggest DNA & RNA production challenges facing vaccines & therapeutics

  • https://quantoom.com/
Corporate interactions BETA
Corporate TypeTweets Articles
EQUANS
EQUANS
Environmental Services
EQUANS
Environmental Services
Other

8 Apr 2024


Noshaq
Noshaq
Venture Capital and Private Equity Principals
Noshaq
Venture Capital and Private Equity Principals
Other

28 Jul 2023


Similar entities
Loading...
Loading...
Social network dynamics